Fatal Yellow Fever in a Kidney Transplant Patient.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 01 02 2019
accepted: 09 05 2019
pubmed: 12 5 2019
medline: 7 1 2021
entrez: 12 5 2019
Statut: ppublish

Résumé

A kidney-transplanted patient, unvaccinated against yellow fever (YF), developed high fever, progressed rapidly to hepatic insufficiency and coma, and died 8 days later. Real-time polymarase chain reaction for YF virus collected on the seventh day of symptoms was positive. Autopsy showed disseminated infection and midzonal hepatitis with apoptotic hepatocytes and minimal inflammatory reaction.

Identifiants

pubmed: 31077273
pii: 5488071
doi: 10.1093/cid/ciz389
doi:

Substances chimiques

Yellow Fever Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-148

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Lígia C Pierrotti (LC)

Infectious Diseases Division, Hospital das Clinicas, Universidade de São Paulo, Brazil.
Center for Clinical Research, Diagnósticos da América Laboratory, Brazil.

Amaro N Duarte-Neto (AN)

Pathology Department, Hospital das Clinicas, Universidade de São Paulo, Brazil.

Alice T W Song (ATW)

LIM-37, Liver Transplantation Laboratory, Universidade de São Paulo, Brazil.

Carlucci G Ventura (CG)

Renal Transplantation Service, Hospital das Clinicas, Universidade de São Paulo, Brazil.

Elias David-Neto (E)

Renal Transplantation Service, Hospital das Clinicas, Universidade de São Paulo, Brazil.

Luiz S Azevedo (LS)

Renal Transplantation Service, Hospital das Clinicas, Universidade de São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH